INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 422m ago
HOUSE PTR22m ago
SEC 13F22m ago
ROBINHOOD CHAIN22m ago
Public company

ILLUMINA, INC.

ILMNCIK 0001110803

EDGAR filingsOpen in network
Price$213.13
1 year+74.1%
Disclosed transactions1
Buys / sells1 / 0
Max Insider Score24
Connections with evidence7

ILMN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
Gilbert Ray Cisneros, Jr.DSelf
ILMNILLUMINA, INC.
Purchase
BUY$1,001 – $15KFeb 10, 2026

Verified connections

  • ← Lobbied forevidence
    JEFFREY J. KIMBELL & ASSOCIATES, INC.LDA Q2 2026 second quarter · Health issues, Budget/appropriations · Aug 26, 2026
  • ← Lobbied forevidence
    THORN RUN PARTNERSLDA RR 2026 second quarter · Budget/appropriations · Aug 26, 2026
  • ← Lobbied forevidence
    AVENUE SOLUTIONSLDA Q1 2026 first quarter · Health issues, Trade · Aug 26, 2026
  • ← Lobbied forevidence
    MILLER STRATEGIES, LLCLDA Q2 2026 second quarter · Trade · Aug 26, 2026
  • ← Lobbied forevidence
Mar 9, 2026
traded Feb 10, 2026
+27d
HOUSE PTR

Evidence

TODD STRATEGY GROUP
LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Trade · Aug 26, 2026
  • ← Holdsevidence
    ARK Investment Management LLC1.2% of reported portfolio · Aug 14, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-03-09 · Mar 9, 2026
  • Lobbying

    $620K reported · de-duplicated
    2026 Q2 $300K in-house2026 Q1 $320K in-house
    • MILLER STRATEGIES, LLC$80K2026 Q1 · posted Aug 26, 2026 · Trade
    • MILLER STRATEGIES, LLC$80K2026 Q2 · posted Aug 26, 2026 · Trade
    • JEFFREY J. KIMBELL & ASSOCIATES, INC.$19K2026 Q2 · posted Aug 26, 2026 · Health issues, Budget/appropriations
    • In-house report$300K2026 Q2 · posted Aug 26, 2026 · Health issues, Homeland security, Medicare/Medicaid, Trade
    • JEFFREY J. KIMBELL & ASSOCIATES, INC.$19K2026 Q1 · posted Aug 26, 2026 · Health issues, Budget/appropriations
    • THORN RUN PARTNERS$30K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations
    • TODD STRATEGY GROUP$80K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Trade
    • AVENUE SOLUTIONS$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Trade
    • In-house report$320K2026 Q1 · posted Aug 26, 2026 · Budget/appropriations, Health issues, Homeland security, Medicare/Medicaid, Trade
    • THORN RUN PARTNERS—2026 Q2 · posted Aug 26, 2026 · Budget/appropriations
    • AVENUE SOLUTIONS$60K2026 Q2 · posted Aug 26, 2026 · Health issues, Trade
    • TODD STRATEGY GROUP$80K2026 Q2 · posted Aug 26, 2026 · Trade, Health issues, Medicare/Medicaid

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.